Clinical Trial Update: Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating allogeneic cord blood cells for adults with severe spinal cord contusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Contusion

Drugs mentioned

• Allogeneic cord blood cells

Snippet

Sponsor: Sklifosovsky Institute of Emergency Care | Conditions: Spinal Cord Contusion | Phase 1, Phase 2 | Status: COMPLETED